BRONCUS’S DISPOSABLE NEBULIZING MICRO-CATHETER FOR ENDOSCOPE WAS APPROVED FOR MARKETING IN CHINA AND ITS APPLICATIONS IN DRUG-DEVICE COMBINATION WILL BE BROADENED
HANGZHOU, China, Oct. 31, 2022 /PRNewswire/ -- Broncus is pleased to announce that on October 28, 2022, the Company's innovative product in the field of drug-device combination, "Mist FountainTM" (the "Product" or "Nebulizing Micro-Catheter"), a disposable nebulizing micro-catheter for endoscope, has been officially approved for marketing by Zhejiang Medical Products Administration. Currently, the Product is the only nebulizing micro-catheter...
G20 Health Ministers Meeting Delivers Six Key Actions for the Upcoming Leaders’ Summit
BALI, Oct. 31, 2022 /PRNewswire/ -- Indonesian Health Minister Budi Gunadi Sadikin closed G20 Second Health Ministerial Meeting in Bali, 28 October 2022. This meeting is the culmination of G20 discussions about strengthening the global health architecture and strengthening pandemic prevention, preparedness and response. G20 Health Ministers Meeting Produced Key Actions to Strengthen Global Health...
Bowtie partners with Take2 and SCOR to develop an innovative cancer screening solution, sponsor over 1,000 high-risk customers to conduct early nasopharyngeal cancer detection test
85% of nasopharyngeal cancer patients are from Asia. Early detection increases survival rate by nearly 30% HONG KONG, Oct. 31, 2022 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer, announce its partnership with Take2, a healthcare and biotech company, and SCOR, a leading French reinsurer, to develop an innovative cancer screening solution. Bowtie will sponsor 1,300 of its selected life...
Infinitus joins hands with some of the world’s most prestigious universities in international sci-tech government project
The Chinese herbal health products maker teams up with South China University of Technology, Cambridge University and others institutions of higher learning in immune system enhancement and anti-aging study GUANGZHOU, China, Oct. 29, 2022 /PRNewswire/ -- In September of this year, the International Industrial Application Demonstration of Functional Foods for Delaying Aging and Enhancing Immunity project, led by...
Akeso Announces Oral Presentation of Ivonescimab (PD-1/VEGF Bi-Specific) in First-line Treatment of ES-SCLC on ACLC 2022
HONG KONG, Oct. 31, 2022 /PRNewswire/ -- Akeso, Biopharma (9926. HK) ("Akeso") released the Phase Ib clinical results of Ivonescimab (PD-1/VEGF bi-specific, AK112) in combination with etoposide and carboplatin in first-line treatment of extensive-stage small-cell lung cancer(ES-SCLC), in an oral presentation at the IASLC 2022 Asia Conference on Lung Cancer. Preliminary data...
Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 (Recombinant anti-Claudin18.2 Monoclonal Antibody-drug Conjugate) in Patients with Advanced Solid Tumors
ROCKVILLE, Md. and SUZHOU, China, Oct. 30, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, announced that the first patient was dosed in Australia for its proprietary anti-Claudin18.2 monoclonal antibody-drug conjugate(ADC) (R&D code: IBI343) in Phase...
Samyang Holdings’ Lafullen Makes Splash in Korean Medical Aesthetics Market
- Successfully demonstrated Lafullen's safety and efficacy at autumn medical symposiums - Shared treatment protocols and clinical cases to lecturers by specialist - Continued to develop evidence-based marketing to Asian markets SEOUL, South Korea, Oct. 31, 2022 /PRNewswire/ -- Samyang Holdings Biopharmaceuticals Division (CEO: Lee Young-Joon) participated in recent autumn medical symposiums in Korea to raise awareness of...
Unload Psoriatic Disease: World Psoriasis Day 2022
STOCKHOLM, Oct. 29, 2022 /PRNewswire/ -- World Psoriasis Day is October 29th. Each year, the global psoriatic disease community unites for action to raise awareness of psoriatic disease. This year's theme is mental health. Vicious Cycle World Psoriasis Day 2022 1 in 10 people with psoriatic disease is diagnosed...
World Stroke Organization Tackle Gaps in Access to Quality Stroke Care
GENEVA, Switzerland, Oct. 28, 2022 /PRNewswire/ -- On World Stroke Day (29th Oct), the World Stroke Organization has announced the launch of a new program that aims to drive access to quality acute stroke care and save lives around the world. What happens in the minutes after someone has a...
GORE COMPLETES FIRST IN-HUMAN IMPLANTS OF THE GORE® VIAFORT VASCULAR STENT
CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease. FLAGSTAFF, Ariz., Oct. 29, 2022 /PRNewswire/ -- W. L. Gore & Associates (Gore) today announced the first implants...
